Home›Companies›Biotech & Pharma›GPN Vaccines

GPN Vaccines, Inc.

Develops bacterial vaccines for adults, children and animals.

Updated Nov 16, 2026·Latest SEC filing Jan 28, 2026·Suggest an edit

About GPN Vaccines

GPN Vaccines is a private company based in Wilmington, Delaware, incorporated in 2025 in Delaware. It has reported $3,500,000 raised in one offering on Form D since January 2026. Its chief executive is Timothy Hirst.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 24, 2025Jan 28, 2026$3,500,000of $10.0M target63$55,556Equity, OptionsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on GPN Vaccines's Form D filed Jan 28, 2026.

Timothy Hirst
Timothy Hirst
Chairman and CEO
James Selkirk
James Selkirk
Chief Financial Officer

Sources

  1. SECGPN VACCINES, INC. filing history
  2. CompanyContact GPN Vaccines
  3. CompanyAbout GPN Vaccines
  4. CompanyBoard changes
  5. CompanyR&D tax incentive refund
  6. PressVaccine program update